Javascript must be enabled to continue!
Haemodynamic monitoring and management in patients having noncardiac surgery
View through CrossRef
BACKGROUND
Haemodynamic monitoring and management is a mainstay of peri-operative anaesthetic care.
OBJECTIVE
To determine how anaesthesiologists measure and manage blood pressure and cardiac output, and how they guide fluid administration and assess fluid responsiveness in patients having noncardiac surgery.
DESIGN
Web-based survey.
SETTING
Survey among members of the European Society of Anaesthesiology and Intensive Care (ESAIC) in October and November 2021.
PARTICIPANTS
ESAIC members responding to the survey.
MAIN OUTCOME MEASURES
Respondents’ answers to 30 questions on haemodynamic monitoring and management, and fluid therapy.
RESULTS
A total of 615 fully completed surveys were analysed. Arterial catheters are usually not placed before induction of general anaesthesia (378/615; 61%) even when invasive blood pressure monitoring is planned. Mean arterial pressure (532/615; 87%) with lower intervention thresholds of 65 mmHg (183/531; 34%) or 20% below pre-operative baseline (166/531; 31%) is primarily used to guide blood pressure management. Cardiac output is most frequently measured using pulse wave analysis (548/597; 92%). However, only one-third of respondents (almost) always use cardiac output to guide haemodynamic management in high-risk patients (225/582; 39%). Dynamic cardiac preload variables are more frequently used to guide haemodynamic management than cardiac output [pulse pressure variation (almost) always: 318/589; 54%]. Standardised treatment protocols are rarely used for haemodynamic management (139/614; 23%). For fluid therapy, crystalloids are primarily used as maintenance fluids, to treat hypovolaemia, and for fluid challenges. The use of 0.9% saline and hydroxyethyl starch has declined over the last decade. The preferred methods to assess fluid responsiveness are dynamic preload variables and fluid challenges, most commonly with 250 ml of fluid (319/613; 52%).
CONCLUSION
This survey provides important information how anaesthesiologists currently measure and manage blood pressure and cardiac output, and how they guide fluid administration in patients having noncardiac surgery.
Ovid Technologies (Wolters Kluwer Health)
Title: Haemodynamic monitoring and management in patients having noncardiac surgery
Description:
BACKGROUND
Haemodynamic monitoring and management is a mainstay of peri-operative anaesthetic care.
OBJECTIVE
To determine how anaesthesiologists measure and manage blood pressure and cardiac output, and how they guide fluid administration and assess fluid responsiveness in patients having noncardiac surgery.
DESIGN
Web-based survey.
SETTING
Survey among members of the European Society of Anaesthesiology and Intensive Care (ESAIC) in October and November 2021.
PARTICIPANTS
ESAIC members responding to the survey.
MAIN OUTCOME MEASURES
Respondents’ answers to 30 questions on haemodynamic monitoring and management, and fluid therapy.
RESULTS
A total of 615 fully completed surveys were analysed.
Arterial catheters are usually not placed before induction of general anaesthesia (378/615; 61%) even when invasive blood pressure monitoring is planned.
Mean arterial pressure (532/615; 87%) with lower intervention thresholds of 65 mmHg (183/531; 34%) or 20% below pre-operative baseline (166/531; 31%) is primarily used to guide blood pressure management.
Cardiac output is most frequently measured using pulse wave analysis (548/597; 92%).
However, only one-third of respondents (almost) always use cardiac output to guide haemodynamic management in high-risk patients (225/582; 39%).
Dynamic cardiac preload variables are more frequently used to guide haemodynamic management than cardiac output [pulse pressure variation (almost) always: 318/589; 54%].
Standardised treatment protocols are rarely used for haemodynamic management (139/614; 23%).
For fluid therapy, crystalloids are primarily used as maintenance fluids, to treat hypovolaemia, and for fluid challenges.
The use of 0.
9% saline and hydroxyethyl starch has declined over the last decade.
The preferred methods to assess fluid responsiveness are dynamic preload variables and fluid challenges, most commonly with 250 ml of fluid (319/613; 52%).
CONCLUSION
This survey provides important information how anaesthesiologists currently measure and manage blood pressure and cardiac output, and how they guide fluid administration in patients having noncardiac surgery.
Related Results
Myocardial Injury After Noncardiac Surgery in Major General Surgical Patients a Prospective Observational Cohort Study
Myocardial Injury After Noncardiac Surgery in Major General Surgical Patients a Prospective Observational Cohort Study
Objective:
The objective of this study was to determine the prognostic relevance, clinical characteristics, and 30-day outcomes associated with myocardial injury after ...
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Divergent Conceptualizations and Management Strategies for Neurogenic Thoracic Outlet Syndrome: A Qualitative Multispecialty Study
Abstract
Background
Neurogenic thoracic outlet syndrome (nTOS) is the most prevalent subtype of thoracic outlet syndrome and remains one of the most controversial conditions in per...
Guest Editorial – Pulmonary Embolism: the risk of what we don’t yet know!
Guest Editorial – Pulmonary Embolism: the risk of what we don’t yet know!
Pulmonary embolism (PE) is a common and potentially life-threatening condition encountered routinely in acute care.1, 2 The diagnosis and management of PE has been the topic of Nat...
Risk factor analysis of enterocutaneous fistula after small bowel surgery
Risk factor analysis of enterocutaneous fistula after small bowel surgery
Abstract:
Background: ECF most frequently follows a complication of abdominal surgery, although a smaller number occur spontaneously in association with conditia
Background: Entero...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
5-Year haemodynamic performance of three aortic bioprostheses. A randomized clinical trial
5-Year haemodynamic performance of three aortic bioprostheses. A randomized clinical trial
Abstract
OBJECTIVES
The Carpentier Perimount (CP) Magna Ease, the Crown Phospholipid Reduction Treatment (PRT) a...
Cardiac perioperative complications in noncardiac surgery
Cardiac perioperative complications in noncardiac surgery
Anesthesiologists are confronted with an increasing population of patients undergoing noncardiac surgery who are at risk for cardiac complications in the perioperative period. Peri...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...

